KR0183012B1 - 알파-글리코시다제 억제제 - Google Patents
알파-글리코시다제 억제제 Download PDFInfo
- Publication number
- KR0183012B1 KR0183012B1 KR1019900016003A KR900016003A KR0183012B1 KR 0183012 B1 KR0183012 B1 KR 0183012B1 KR 1019900016003 A KR1019900016003 A KR 1019900016003A KR 900016003 A KR900016003 A KR 900016003A KR 0183012 B1 KR0183012 B1 KR 0183012B1
- Authority
- KR
- South Korea
- Prior art keywords
- benzyl
- methyl
- tri
- dideoxy
- imino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP89402794A EP0422307A1 (en) | 1989-10-10 | 1989-10-10 | Novel alpha-glucosidase inhibitors |
| EP894027945 | 1989-10-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR910007951A KR910007951A (ko) | 1991-05-30 |
| KR0183012B1 true KR0183012B1 (ko) | 1999-04-01 |
Family
ID=8202997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019900016003A Expired - Fee Related KR0183012B1 (ko) | 1989-10-10 | 1990-10-10 | 알파-글리코시다제 억제제 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5097023A (cg-RX-API-DMAC10.html) |
| EP (2) | EP0422307A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP3032266B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR0183012B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN1029974C (cg-RX-API-DMAC10.html) |
| AR (1) | AR246745A1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE109153T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU632855B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2027276C (cg-RX-API-DMAC10.html) |
| DE (1) | DE69011033T2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK0422975T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2060980T3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI101796B (cg-RX-API-DMAC10.html) |
| HU (1) | HU209724B (cg-RX-API-DMAC10.html) |
| IE (1) | IE64079B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL95928A (cg-RX-API-DMAC10.html) |
| NO (1) | NO174203C (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ235578A (cg-RX-API-DMAC10.html) |
| PT (1) | PT95547B (cg-RX-API-DMAC10.html) |
| TW (1) | TW225539B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA907936B (cg-RX-API-DMAC10.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
| US5268364A (en) * | 1991-12-12 | 1993-12-07 | The Biomembrane Institute | Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification |
| US5843921A (en) | 1994-03-15 | 1998-12-01 | Childrens Hospital Of Los Angeles | Therapeutic food composition and method to diminish blood sugar fluctuations |
| US5605893A (en) * | 1994-03-15 | 1997-02-25 | Children's Hospital Of Los Angeles | Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients |
| JP3580900B2 (ja) * | 1995-04-20 | 2004-10-27 | ホクレン農業協同組合連合会 | α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料 |
| US5929037A (en) * | 1995-06-07 | 1999-07-27 | Alberta Research Council | Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues |
| EP0858335B1 (en) * | 1995-09-08 | 2003-03-12 | Novo Nordisk A/S | 2-alkylpyrrolidines |
| WO1998009981A1 (en) * | 1996-09-09 | 1998-03-12 | Wisconsin Alumni Research Foundation | Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity |
| US6534487B1 (en) | 1999-08-03 | 2003-03-18 | Childrens Hospital Los Angeles | Methods for suppressing appetite and enhancing exercise and recovery |
| EP1270598A4 (en) * | 1999-12-21 | 2003-05-02 | Ajinomoto Kk | PARTIAL ESTER OF CELLULOSE WITH NITROGEN CARBOXYLIC ACID AND PRODUCTION METHOD |
| JP4486792B2 (ja) * | 2003-06-12 | 2010-06-23 | 学校法人近畿大学 | 環状オニウム化合物およびグルコシダーゼ阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
-
1989
- 1989-10-10 EP EP89402794A patent/EP0422307A1/en not_active Withdrawn
-
1990
- 1990-09-17 US US07/583,545 patent/US5097023A/en not_active Expired - Fee Related
- 1990-09-21 AT AT90402613T patent/ATE109153T1/de not_active IP Right Cessation
- 1990-09-21 DK DK90402613.5T patent/DK0422975T3/da active
- 1990-09-21 EP EP90402613A patent/EP0422975B1/en not_active Expired - Lifetime
- 1990-09-21 ES ES90402613T patent/ES2060980T3/es not_active Expired - Lifetime
- 1990-09-21 DE DE69011033T patent/DE69011033T2/de not_active Expired - Fee Related
- 1990-10-04 ZA ZA907936A patent/ZA907936B/xx unknown
- 1990-10-04 AU AU63756/90A patent/AU632855B2/en not_active Ceased
- 1990-10-05 NZ NZ235578A patent/NZ235578A/en unknown
- 1990-10-05 TW TW079108368A patent/TW225539B/zh active
- 1990-10-09 HU HU906389A patent/HU209724B/hu not_active IP Right Cessation
- 1990-10-09 FI FI904965A patent/FI101796B/fi not_active IP Right Cessation
- 1990-10-09 JP JP2269667A patent/JP3032266B2/ja not_active Expired - Fee Related
- 1990-10-09 AR AR90318034A patent/AR246745A1/es active
- 1990-10-09 IE IE361390A patent/IE64079B1/en not_active IP Right Cessation
- 1990-10-09 IL IL9592890A patent/IL95928A/en not_active IP Right Cessation
- 1990-10-09 NO NO904372A patent/NO174203C/no not_active IP Right Cessation
- 1990-10-09 PT PT95547A patent/PT95547B/pt not_active IP Right Cessation
- 1990-10-10 CN CN90108284A patent/CN1029974C/zh not_active Expired - Fee Related
- 1990-10-10 KR KR1019900016003A patent/KR0183012B1/ko not_active Expired - Fee Related
- 1990-10-10 CA CA002027276A patent/CA2027276C/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0155541B1 (ko) | 1-데옥시 노지리마이신 유도체 및 약제학적으로 허용되는 이의 산 부가염, 및 이의 제조방법 | |
| US5504078A (en) | α-glucosidase inhibitors | |
| CA1240989A (en) | Homodisaccharide hypoglycemic agents | |
| KR0183012B1 (ko) | 알파-글리코시다제 억제제 | |
| JP3773450B2 (ja) | グルコピラノシルオキシベンジルベンゼン誘導体、それを含有する医薬組成物およびその製造中間体 | |
| WO1994009020A1 (fr) | Nouveau shingoglycolipide et son utilisation | |
| US5053498A (en) | Therapeutic and prophylactic agents for peptic ulcer | |
| JP3136491B2 (ja) | 新規なα―グルコシダーゼ抑制剤 | |
| JPH0631298B2 (ja) | 新規アンスラサイクリン誘導体,抗腫瘍剤,及び製造法 | |
| EP0345104B1 (en) | Novel Alpha-glucosidase inhibitors | |
| EP0389723A1 (en) | Novel alpha-glucosidase inhibitors | |
| EP0461223A1 (en) | Novel 1-triacontanol derivatives | |
| US20030100515A1 (en) | Benzophenone glycopyranosides, preparation and therapeutic use | |
| Kloosterman et al. | Alternative synthesis and regioselective coupling of 1, 6‐anhydro‐2‐azido‐and‐2‐phthalimido‐2‐deoxy‐β‐D‐galactopyranose | |
| JP4794285B2 (ja) | ベンジルフェノール誘導体またはその塩 | |
| Stevens et al. | Synthesis and reactions of methyl 2, 3-di-O-benzyl-4, 6-dideoxy-. alpha.-D-threo-hex-4-enopyranoside |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| FPAY | Annual fee payment |
Payment date: 20021206 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20031216 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20031216 |